Lineage Cell Therapeutics, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Lineage Cell Therapeutics, Inc. (LCTX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$2.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-06
- Lineage Cell Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$341.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$1.71M.
- Lineage Cell Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $2.46M, a 2435.05% increase year-over-year.
- Lineage Cell Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $271.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $2.27M.
- Lineage Cell Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$1.68M.
- Lineage Cell Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$2.29M.
- Lineage Cell Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$18.70M, a 186.40% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$341.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.05M 10-Q · filed 2026-08-06 | $407.00K derived: sum of 3 quarters · filed 2026-08-06 | $678.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$1.71M 10-Q · filed 2026-05-12 | $748.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.02M derived: sum of 3 quarters · filed 2026-05-12 | $665.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.73M derived: sum of 2 quarters · filed 2026-03-05 | $2.38M derived: sum of 3 quarters · filed 2026-08-06 | $2.27M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$83.00K derived: sum of 2 quarters · filed 2026-08-06 | -$188.00K 10-Q · filed 2025-11-06 | -$91.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$459.00K 10-Q · filed 2026-08-06 | -$362.00K derived: sum of 3 quarters · filed 2026-08-06 | -$895.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$105.00K 10-Q · filed 2026-05-12 | -$8.00K derived: sum of 2 quarters · filed 2026-05-12 | -$541.00K derived: sum of 3 quarters · filed 2026-05-12 | -$1.21M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$436.00K derived: sum of 2 quarters · filed 2026-03-05 | -$1.11M derived: sum of 3 quarters · filed 2026-03-05 | -$1.68M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | -$533.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.20M derived: sum of 2 quarters · filed 2025-11-06 | -$1.78M 10-Q · filed 2025-11-06 | -$617.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$671.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.25M 10-Q · filed 2025-08-12 | -$84.00K derived: sum of 3 quarters · filed 2025-08-12 | $401.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$574.00K 10-Q · filed 2025-05-13 | $587.00K derived: sum of 2 quarters · filed 2025-05-13 | $1.07M derived: sum of 3 quarters · filed 2025-05-13 | $594.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $1.65M derived: sum of 2 quarters · filed 2025-03-10 | $1.17M derived: sum of 3 quarters · filed 2025-03-10 | -$2.29M 10-K · filed 2025-03-10 | ||||
| 2023-09-30 | $485.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $7.00K derived: sum of 2 quarters · filed 2024-11-14 | -$3.46M 10-Q · filed 2024-11-14 | -$4.58M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$478.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$3.94M 10-Q · filed 2024-08-08 | -$5.07M derived: sum of 3 quarters · filed 2024-08-08 | -$3.41M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$3.46M 10-Q · filed 2024-05-09 | -$4.59M derived: sum of 2 quarters · filed 2024-05-09 | -$2.94M derived: sum of 3 quarters · filed 2024-05-09 | -$3.26M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $528.00K derived: sum of 2 quarters · filed 2024-03-07 | $203.00K derived: sum of 3 quarters · filed 2024-03-07 | -$18.70M 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.33M derived: sum of 2 quarters · filed 2023-11-09 | -$17.57M 10-Q · filed 2023-11-09 | $3.72M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$325.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$19.23M 10-Q · filed 2023-08-10 | $2.06M derived: sum of 3 quarters · filed 2023-08-10 | $3.37M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$18.91M 10-Q · filed 2023-05-11 | $2.39M derived: sum of 2 quarters · filed 2023-05-11 | $3.69M derived: sum of 3 quarters · filed 2023-05-11 | $3.77M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $21.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $22.60M derived: sum of 2 quarters · filed 2023-03-09 | $22.68M derived: sum of 3 quarters · filed 2023-03-09 | $21.64M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.39M derived: sum of 2 quarters · filed 2022-11-10 | $354.00K 10-Q · filed 2022-11-10 | -$680.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$955.00K 10-Q · filed 2022-08-11 | -$1.99M derived: sum of 3 quarters · filed 2022-08-11 | -$861.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$1.03M 10-Q · filed 2022-05-12 | -$2.06M derived: sum of 2 quarters · filed 2022-05-12 | -$937.00K derived: sum of 3 quarters · filed 2022-05-12 | -$585.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $94.00K derived: sum of 2 quarters · filed 2022-03-10 | $446.00K derived: sum of 3 quarters · filed 2022-03-10 | $308.00K 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.48M derived: sum of 2 quarters · filed 2021-11-10 | $1.34M 10-Q · filed 2021-11-10 | $1.25M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $214.00K 10-Q · filed 2021-08-12 | $117.00K derived: sum of 3 quarters · filed 2021-08-12 | -$1.87M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$138.00K 10-Q · filed 2021-05-13 | -$235.00K derived: sum of 2 quarters · filed 2021-05-13 | -$2.22M derived: sum of 3 quarters · filed 2021-05-13 | -$2.78M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$2.08M derived: sum of 2 quarters · filed 2021-03-11 | -$2.64M derived: sum of 3 quarters · filed 2021-03-11 | -$2.88M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$2.55M derived: sum of 2 quarters · filed 2020-11-04 | -$2.79M 10-Q · filed 2020-11-04 | -$1.37M derived: sum of 4 quarters · filed 2020-11-04 | ||||
| 2019-06-30 | -$563.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$804.00K 10-Q · filed 2020-08-06 | $610.00K derived: sum of 3 quarters · filed 2020-08-06 | $632.00K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$241.00K 10-Q · filed 2020-05-07 | $1.17M derived: sum of 2 quarters · filed 2020-05-07 | $1.20M derived: sum of 3 quarters · filed 2020-05-07 | $1.70M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.44M derived: sum of 2 quarters · filed 2020-03-12 | $1.94M derived: sum of 3 quarters · filed 2020-03-12 | $1.10M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $526.00K derived: sum of 2 quarters · filed 2019-11-12 | -$314.00K 10-Q · filed 2019-11-12 | -$291.00K derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $504.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$336.00K 10-Q · filed 2019-08-08 | -$313.00K derived: sum of 3 quarters · filed 2019-08-08 | $122.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$840.00K 10-Q · filed 2019-05-09 | -$817.00K derived: sum of 2 quarters · filed 2019-05-09 | -$382.00K derived: sum of 3 quarters · filed 2019-05-09 | -$196.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $458.00K derived: sum of 2 quarters · filed 2019-03-14 | $644.00K derived: sum of 3 quarters · filed 2019-03-14 | $1.30M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | $435.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $621.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.28M 10-Q · filed 2018-11-08 | $889.00K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $841.00K 10-Q · filed 2018-08-02 | $454.00K derived: sum of 3 quarters · filed 2018-08-02 | $1.06M derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | $655.00K 10-Q · filed 2018-05-10 | $268.00K derived: sum of 2 quarters · filed 2018-05-10 | $878.00K derived: sum of 3 quarters · filed 2018-05-10 | -$790.00K derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$387.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $223.00K derived: sum of 2 quarters · filed 2018-03-15 | -$1.45M derived: sum of 3 quarters · filed 2018-03-15 | $12.00K 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | $610.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$1.06M derived: sum of 2 quarters · filed 2017-11-09 | $399.00K 10-Q · filed 2017-11-09 | $367.00K 10-Q · filed 2016-11-04 | $1.56M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2016-06-30 | -$1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$211.00K 10-Q · filed 2017-08-09 | $950.00K derived: sum of 3 quarters · filed 2018-03-15 | $2.27M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-03-31 | $1.46M 10-Q · filed 2017-05-10 | $2.62M derived: sum of 2 quarters · filed 2018-03-15 | $3.94M derived: sum of 3 quarters · filed 2018-03-15 | $3.50M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.48M derived: sum of 2 quarters · filed 2018-03-15 | $2.04M derived: sum of 3 quarters · filed 2018-03-15 | $1.67M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $877.00K derived: sum of 2 quarters · filed 2016-11-04 | $512.00K 10-Q · filed 2016-11-04 | $1.59M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | -$445.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$810.00K 10-Q · filed 2016-08-09 | -$811.00K 10-Q · filed 2015-08-10 | $265.00K derived: sum of 3 quarters · filed 2017-03-16 | $755.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | -$365.00K 10-Q · filed 2016-05-10 | -$365.18K 10-Q · filed 2015-05-08 | $710.00K derived: sum of 2 quarters · filed 2017-03-16 | $1.20M derived: sum of 3 quarters · filed 2017-03-16 | $441.21K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.56M derived: sum of 2 quarters · filed 2017-03-16 | $806.21K derived: sum of 3 quarters · filed 2017-03-16 | -$470.00K 10-K · filed 2017-03-16 | -$469.75K 10-K · filed 2015-03-11 | |||
| 2014-09-30 | $490.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$268.79K derived: sum of 2 quarters · filed 2015-11-09 | -$1.54M 10-Q · filed 2015-11-09 | -$1.54M 10-Q · filed 2014-11-07 | $419.37K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | -$758.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$2.04M 10-Q · filed 2015-08-10 | -$2.03M 10-Q · filed 2014-08-11 | -$70.63K derived: sum of 3 quarters · filed 2016-03-15 | $137.87K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | -$1.28M 10-Q · filed 2015-05-08 | $688.16K derived: sum of 2 quarters · filed 2016-03-15 | $896.65K derived: sum of 3 quarters · filed 2016-03-15 | $967.11K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $2.17M derived: sum of 2 quarters · filed 2016-03-15 | $2.24M derived: sum of 3 quarters · filed 2016-03-15 | $2.14M 10-K · filed 2016-03-15 | $2.13M 10-K · filed 2014-03-17 | |||
| 2013-09-30 | $208.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $278.95K derived: sum of 2 quarters · filed 2014-11-07 | $177.63K 10-Q · filed 2014-11-07 | $1.78M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-06-30 | $70.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$30.86K 10-Q · filed 2014-08-11 | $1.57M derived: sum of 3 quarters · filed 2015-03-11 | $1.25M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-03-31 | -$101.32K 10-Q · filed 2014-05-12 | $1.50M derived: sum of 2 quarters · filed 2015-03-11 | $1.18M derived: sum of 3 quarters · filed 2015-03-11 | $1.88M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2012-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $1.28M derived: sum of 2 quarters · filed 2015-03-11 | $1.98M derived: sum of 3 quarters · filed 2015-03-11 | $906.34K 10-K · filed 2015-03-11 | $894.98K 10-K · filed 2013-03-18 | |||
| 2012-09-30 | -$325.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $375.79K derived: sum of 2 quarters · filed 2013-11-12 | -$699.15K 10-Q · filed 2013-11-12 | $232.31K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | $701.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$373.56K 10-Q · filed 2013-08-09 | $557.91K derived: sum of 3 quarters · filed 2014-03-17 | $87.51K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | -$1.07M 10-Q · filed 2013-05-10 | -$143.48K derived: sum of 2 quarters · filed 2014-03-17 | -$613.88K derived: sum of 3 quarters · filed 2014-03-17 | -$107.35K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | $931.47K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $461.06K derived: sum of 2 quarters · filed 2014-03-17 | $967.60K derived: sum of 3 quarters · filed 2014-03-17 | $600.40K 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | -$470.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $36.13K derived: sum of 2 quarters · filed 2012-11-09 | -$331.07K 10-Q · filed 2012-11-09 | -$581.07K 10-Q · filed 2011-11-08 | -$21.42K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-06-30 | $506.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $139.33K 10-Q · filed 2012-08-09 | -$110.67K 10-Q · filed 2011-08-09 | $448.99K derived: sum of 3 quarters · filed 2013-03-18 | $428.31K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-03-31 | -$367.20K 10-Q · filed 2012-05-10 | -$57.55K derived: sum of 2 quarters · filed 2013-03-18 | -$78.23K derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | $309.65K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $288.97K derived: sum of 2 quarters · filed 2013-03-18 | $254.09K 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | -$20.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$55.56K 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | -$34.88K 10-Q · filed 2011-08-09 | |||||||
| 2009-12-31 | -$419.46K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |